Nuvation Bio Inc
Company Profile
Business description
Nuvation Bio Inc is a biopharmaceutical company tackling unmet needs in oncology by developing differentiated and novel therapeutic candidates. The company's clinical-stage product candidate is NUV-868, a BD2-selective oral small molecule BET inhibitor. NUV-868 inhibits the protein BRD4, a key member of the BET family that epigenetically regulates a number of important proteins that control tumor growth and differentiation, including oncogenes such as c-myc. Notably, BET proteins have critical biological functions and are found to be altered in many human cancers. It is also developing its proprietary, small molecule Drug-Drug Conjugate (DDC) platform, a novel therapeutic approach within the drug-conjugate class of anti-cancer therapies with parallels to Antibody-Drug Conjugates (ADCs).
Contact
1500 Broadway
Suite 1401
New York NY 10036
USAT: +1 332 208-6102
Sector
Healthcare
Stock type
Defensive
Industry
Biotechnology
Fiscal Year End
31 December 2024
Employees
159
Morningstar Investment Ideas
Stocks
ETFs
- Australian ETFs
- Active Australian Equity ETFs
- Passive Australian Equity ETFs
- Emerging Market Equity ETFs
- Sustainable ETFs
- Active Global Equity ETFs
- Passive Global Equity ETFs
- Active Australian Fixed Interest ETFs
- Passive Australian Fixed Interest ETFs
- Active Australian Listed Property ETFs
- Passive Australian Listed Property ETFs
- Active Global Fixed Interest ETFs
- Passive Global Fixed Interest ETFs
- Active Global Infrastructure ETFs
- Passive Global Infrastructure ETFs
- Active Global Property ETFs
- Passive Global Property ETFs
Funds
- Active Australian Equity Funds
- Passive Australian Equity Funds
- Active Global Equity Funds
- Passive Global Equity Funds
- Sustainable Funds
- Emerging Market Equity Funds
- Passive Australian Listed Property Funds
- Active Australian Listed Property Funds
- Passive Global Infrastructure Funds
- Active Global Infrastructure Funds
- Active Global Property Funds
- Passive Global Property Funds
- Active Australian Fixed Interest Funds
- Passive Australian Fixed Interest Funds
- Active Global Fixed Interest Funds
- Passive Global Fixed Interest Funds
Markets
Index
|
Last price
|
Change
|
% Change
|
---|---|---|---|
All Ordinaries | 8,082.30 | 67.80 | -0.83% |
CAC 40 | 8,167.50 | 20.99 | -0.26% |
DAX 40 | 18,704.42 | 34.39 | -0.18% |
Dow JONES (US) | 39,945.98 | 76.60 | 0.19% |
FTSE 100 | 8,420.26 | 18.39 | -0.22% |
HKSE | 19,553.61 | 177.08 | 0.91% |
NASDAQ | 16,692.16 | 6.16 | -0.04% |
Nikkei 225 | 38,787.38 | 132.88 | -0.34% |
NZX 50 Index | 11,699.79 | 28.27 | -0.24% |
S&P 500 | 5,298.74 | 1.64 | 0.03% |
S&P/ASX 200 | 7,814.40 | 66.90 | -0.85% |
SSE Composite Index | 3,154.03 | 31.63 | 1.01% |
Market Movers
Name
|
Last price
|
Change
|
% Change
|
---|---|---|---|
Sayona Mining Ltd SYA | 0.05 | 0.01 | 10.42% |
Tietto Minerals Ltd TIE | 0.67 | 0.01 | -0.75% |
Pantoro Ltd PNR | 0.09 | 0.00 | 4.60% |
Imugene Ltd IMU | 0.07 | 0.00 | 1.41% |
Core Lithium Ltd CXO | 0.17 | 0.01 | 6.45% |
Pilbara Minerals Ltd PLS | 4.10 | 0.09 | 2.24% |
Telstra Group Ltd TLS | 3.67 | 0.02 | -0.54% |
Strike Energy Ltd STX | 0.22 | 0.01 | -4.44% |
De Grey Mining Ltd DEG | 1.17 | 0.02 | -1.27% |
Lake Resources NL LKE | 0.07 | 0.01 | 9.38% |